Here are the 8-K filings from THC Therapeutics Inc (THCT) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow THCT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full THCT filings page.
THC Therapeutics, Inc. terminated its Share Exchange Agreement with ST Holdings Group, LLC on October 30, 2026; the parties mutually agreed to end it because of difficulty accounting for the transaction. They are currently discussing options for the company’s potential future acquisition of some or all of ST Holdings’ assets.
An amended designation filed July 7, 2026, provides for 500,000 shares of preferred stock to be designated as Series D Convertible Preferred Stock. Under the amendment, each share is entitled to 10 votes on matters submitted to a stockholder vote and is convertible into common stock at $0.01 per share.